Insights from 2023 ASCO® Annual Meeting
Y

ASCO® 2023 Insights: "Prognostic Impact of Adjuvant Endocrine Therapy for ER+/HER2- T1a/bN0M0 BC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Yuko Takahashi
By Insights from 2023 ASCO® Annual Meeting FEATURING Yuko Takahashi
94 views
June 15, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
11:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino
28:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
17:39
Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
11:28
Insights from 2023 SABCS

SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk B…

Feat. L. Pusztai
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
50:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"

Feat. S. Tolaney, H. Rugo
17:35
Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
23:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
24:36
ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy
21:37
Dana-Farber Cancer Institute

Standard Treatments for HR+/HER2- mBC in 2023

Feat. S. Sammons
53:42
PleXus Communications

Managing Women's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
18:49
Yale School of Medicine

Menopause and Hot Flashes: What Medications are Available?

Feat. M. Minkin
29:44
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Optimal Duration of Endocrine Therapy for Breast Cancer

Feat. V. Kaklamani
09:41
Insights from 2023 SABCS

SABCS 2023 Insights: "ADAPTcycle Trial - Impact of Age and Ovar…

Feat. O. Gluz
03:05
ecancer

ASCO® 2023 Insights: "Phase III NATALEE Trial - Ribociclib + ET…

Feat. D. Slamon
13:17
Jennifer Sass

US EPA Evaluation of Endocrine Disrupting Chemicals (EDCs)

07:34
PrecisCa

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

Feat. M. Pegram